Surveillance for linezolid resistance via the Zyvoxw Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): Evolving resistance mechanisms with stable susceptibility rates

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 7, 2016, Pages 1860-1865

  Mendes, Rodrigo E ^a   Hogan, Patricia A ^b   Jones, Ronald N ^a   Sader, Helio S ^a   Flamm, Robert K ^a  

^a JMI LABORATORIES   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BACTERIAL PROTEIN; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; METICILLIN; OXACILLIN; PENICILLIN DERIVATIVE; RIBOSOMAL PROTEIN L3; RIBOSOME PROTEIN; RNA 23S; TEICOPLANIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; BROTH DILUTION; DRUG POTENCY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; IN VITRO STUDY; IRELAND; MALAYSIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MIC50; MIC90; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTRA GENE; PENICILLIN RESISTANCE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS AUSTRALIS; STREPTOCOCCUS CANIS; STREPTOCOCCUS CONSTELLATUS; STREPTOCOCCUS CRISTATUS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUI; STREPTOCOCCUS EQUINUS; STREPTOCOCCUS GALLOLYTICUS; STREPTOCOCCUS GORDONII; STREPTOCOCCUS INFANTIS; STREPTOCOCCUS INTERMEDIUS; STREPTOCOCCUS LUTETIENSIS; STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PARASANGUINIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS SANGUINIS; STREPTOCOCCUS SUIS; STREPTOCOCCUS VESTIBULARIS; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; GENETICS; GLOBAL HEALTH; GRAM POSITIVE BACTERIUM; HUMAN; MICROBIAL SENSITIVITY TEST; MUTATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; GLOBAL HEALTH; GRAM-POSITIVE BACTERIA; HUMANS; LINEZOLID; MICROBIAL SENSITIVITY TESTS; MUTATION; RIBOSOMAL PROTEINS;

EID: 84979036498     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw052     Document Type: Article

References (21)

1. Mendes RE, Deshpande LM, Jones RN. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms. Drug Resist Updat 2014; 17: 1-12
2. Pfizer Inc. Zyvox [package insert]. http://labeling.pfizer.com/ShowLabeling.aspx?id=649
3. O'Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist 2015; 8: 217-30
4. Mendes RE, Hogan PA, Streit JM et al. Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013. Antimicrob Agents Chemother 2015; 59: 2454-7
5. Flamm RK, Mendes RE, Hogan PA et al. In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program. Microbiol Infect Dis 2015; 81: 283-9
6. Mendes RE, Hogan PA, Streit JM et al. Zyvoxw Annual Appraisal of Potency and Spectrum (ZAAPS) Program: report of linezolid activity over nine years (2004-12). J Antimicrob Chemother 2014; 69: 1582-8
7. Decousser JW, Desroches M, Bourgeois-Nicolaos N et al. Susceptibility trends including emergence of linezolid resistance among coagulasenegative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections. Int J Antimicrob Agents 2015; 46: 622-30
8. Yayan J, Ghebremedhin B, Rasche K. No outbreak of vancomycin and linezolid resistance in staphylococcal pneumonia over a 10-year period. PLoS One 2015; 10: e0138895
9. Deshpande LM, Ashcraft DS, Kahn HP et al. Detection of a new cfr-like gene, cfr(B), in Enterococcus faecium isolates recovered fromhuman specimens in the United States as part of the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 2015; 59: 6256-61
10. Wang Y, Lv Y, Cai J et al. A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin. J Antimicrob Chemother 2015; 70: 2182-90
11. Long KS, Poehlsgaard J, Kehrenberg C et al. The cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob Agents Chemother 2006; 50: 2500-5
12. Bonilla H, Huband MD, Seidel J et al. Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain. Clin Infect Dis 2010; 51: 796-800
13. Sanchez Garcia M, De la Torre MA, Morales G et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 2010; 303: 2260-4
14. Shen J, Wang Y, Schwarz S. Presence and dissemination of the multiresistance gene cfr in Gram-positive and Gram-negative bacteria. J Antimicrob Chemother 2013; 68: 1697-706
15. Cai J, Wang Y, Schwarz S et al. Enterococcal isolates carrying the novel oxazolidinone resistance gene optrA from hospitals in Zhejiang, Guangdong, and Henan, China, 2010-2014. Clin Microbiol Infect 2015; 21: 1095.e1-14
16. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Tenth Edition: Approved Standard M07-A10. CLSI, Wayne, PA, USA, 2015
17. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fifth Informational Supplement M100-S25. CLSI, Wayne, PA, USA, 2015
18. EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters: Version 5.0, January 2015. http://www.eucast.org/clinical_breakpoints/
19. Bender J, Strommenger B, Steglich M et al. Linezolid resistance in clinical isolates of Staphylococcus epidermidis from German hospitals and characterization of two cfr-carrying plasmids. J Antimicrob Chemother 2015; 70: 1630-8
20. Karavasilis V, Zarkotou O, Panopoulou M et al. Wide dissemination of linezolid-resistant Staphylococcus epidermidis in Greece is associated with a linezolid-dependent ST22 clone. J Antimicrob Chemother 2015; 70: 1625-9
21. Pournaras S, Ntokou E, Zarkotou O et al. Linezolid dependence in Staphylococcus epidermidis bloodstream isolates. Emerg Infect Dis 2013; 19: 129-32